Center for Veterinary Medicine: Overview Sanja Modric, DVM, PhD

Similar documents
2014 Annual Report on Inspections of Establishments

The United States Pharmacopeia

Introduction to Drug Naming. Angela G. Long, M.S. Senior Vice President, Global Alliances and Organizational Affairs

CDRH Regulated Software

Veterinary Compounding

Guidance for Industry Time and Extent Applications for Nonprescription Drug Products

Minnesota Board of Pharmacy. Guidance on the Compounding of Veterinary Products Approved: March 4, 2015

Guidance for Industry

Guidance for Industry Certification Process for Designated Medical Gases

Guidance for Industry Circumstances that Constitute Delaying, Denying, Limiting, or Refusing a Drug Inspection

FDA s Final Compliance Policy Guide for Marketed Unapproved Drugs Is Agency Enforcement at a Crossroads, or Stuck in a Traffic Circle

Guidance for Industry

Marketed Unapproved Drugs: FDA to Take Immediate Enforcement Action at Any Time, Without Prior Notice

Regulation and Risk Management of Combination Products

United States Pharmacopeia (USP) Quality Standards for Dietary Supplements. Nandu Sarma, PhD, RPh. Director, Dietary Supplements

Guidance for Industry

Preparing for the Pre-Approval Inspection What to do Before the FDA Arrives. Barry A. Friedman, Ph.D. Consultant

Commentary USP 36-NF 31. Excerpt Related to General Chapter <17> Prescription Container Labeling

(1) Cancer drug means a prescription drug that is used to treat cancer or the side effects of cancer.

Guidance for Industry

ENFORCEMENT PRIORITIES FOR DRUG USE IN AQUACULTURE PART A ENFORCEMENT PRIORITIES FOR DRUG USE IN NON-FOOD FISH

[DOCKET NO.96N-0002] DRAFT

IACP Comparison of 503A and 503B The Drug Quality and Security Act of 2013


WHITE PAPER USP S ROLE IN SETTING ENFORCEABLE QUALITY STANDARDS FOR MEDICINES

Enrolled Copy S.B. 55

Guidance for Industry Labeling for Bronchodilators: Cold, Cough, Allergy, Bronchodilator,

Plamena Entcheva-Dimitrov, PhD, RAC On-line Course. 1

Goals & Objectives. Drug Development & the FDA Pharmacy 309. Outline. An History of Disasters. Be able to describe

An Overview of the Regulation of Homeopathic Drug Products in the United States

Office of Acquisitions & Grants Services (OAGS) FDA Small Business Outreach Vendor Fair. February 19, 2014

Drug Development Process

Pre-Approval Process INAD vs. NADA

FDA Regulation of Hearing Aids. Eric A. Mann, MD, PhD Clinical Deputy Director Division of Ophthalmic and ENT Devices ODE/CDRH/FDA

Guidance for Industry

SUPPLY CHAIN INTEGRITY AND SECURITY

Inspections, Compliance, Enforcement, and Criminal Investigations

GUIDELINES FOR THE VALIDATION OF ANALYTICAL METHODS FOR ACTIVE CONSTITUENT, AGRICULTURAL AND VETERINARY CHEMICAL PRODUCTS.

Catalog. Global Education. and Training. Global Expertise Trusted Standards Improved Health

Guidance for Industry

Guidance for Industry

Medical Device Software

What is a medical device? Medical Devices: Roadmap to Market. Kathryn Klaus, Esq.

Combination Products Regulation in the United States

Interplay Between FDA Advertising and Promotion Enforcement Activities, Product Liability, and Consumer Fraud Litigation

General Wellness: Policy for Low Risk Devices. Draft Guidance for Industry and Food and Drug Administration Staff

Correspondence between ISO 13485:2003 and the US Quality System Regulation

Corn Oil Extraction Optimization. Essential Expertise for Water, Energy and Air SM

Guidance for Industry

POLICY AND PROCEDURES OFFICE OF NEW DRUGS. NDAs and BLAs: Communication to Applicants of Planned Review Timelines.

U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) September 2009 OTC

Guidance for Industry

Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE

From the Text. Definitions. Definitions. Definitions. Definitions. RSPT 2217 Basic Concepts & Principles. RSPT Basic Concepts

Guidance for Industry ANDA Submissions Amendments and Easily Correctable Deficiencies Under GDUFA

Guidance for Industry

Adjuvants and Excipients

Pharmacists Pharmacopeia. Official May 1, 2009 August 1, 2009

Development and Validation of In Vitro Diagnostic Tests. YC Lee, Ph.D. CEO

FOOD AND DRUG ADMINISTRATION COMPLIANCE PROGRAM GUIDANCE MANUAL

Coventry Health Care of Georgia, Inc. Coventry Health and Life Insurance Company

Safe%Feed/Safe%Food% Overview of Certification Programs: Why Should a Feed Mill Get Certified?

Best Practices for Use of FoodSHIELD During Food and Feed Incidents

Cosmetics Safety Bill Would Incorporate TSCA Bill Provisions

Disclaimer: The following transcript is a draft and is pending review for accuracy by the speakers. Edits have been made for clarity.

AMBERLITE IRP69 Pharmaceutical Grade Cation Exchange Resin (Sodium Polystyrene Sulfonate USP)

Medical Product Software Development and FDA Regulations Software Development Practices and FDA Compliance

Implementing New USP Chapters for Analytical Method Validation

Guidance for Industry Pyrogen and Endotoxins Testing: Questions and Answers

February 2006 Procedural

One Hundred Twelfth Congress of the United States of America

Department of Defense DIRECTIVE

Step-by-Step Analytical Methods Validation and Protocol in the Quality System Compliance Industry

New Chemical Entity Exclusivity Determinations for Certain Fixed- Combination Drug Products

General Principles for the Safety Assessment of Excipients

Draft Guidance for Industry, Food and Drug Administration Staff, and Clinical Laboratories

Guidance for Industry

MOBILE MEDICAL APPLICATIONS

USP Pharmaceutical Ingredient Supplier Qualification Program. Manual for Participants

Guidance for Industry

The Sheep Safety and Quality Assurance Program. Melissa Garrod-VanLaningham, DVM

Chapter No. 765] PUBLIC ACTS, CHAPTER NO. 765 HOUSE BILL NO By Representatives West, Marrero. Substituted for: Senate Bill No.

Role of the Investigational Drug Services (IDS) in the Management of Investigational Drugs

Annex 9 Guide to good storage practices for pharmaceuticals 1

2014, That Was The Year That Was Greg Baran, RPh, MA, FMPA Baran Consulting LLC

Robert Jarrin Senior Director, Government Affairs. May 22, 2013

CATEGORY Advertising. CATEGORY Biopharmaceutics. CATEGORY Biosimilarity

Office of Acquisitions & Grants Services (OAGS) FDA Small Business Outreach Vendor Fair. March 3, 2015

Subtitle I Sense of the Senate Regarding Medical Malpractice

Enrolled Copy H.B. 128

Re: GRAS Notice No. AGRN

Have you ever wanted to help animals and people stay healthy? Have you ever thought about working in veterinary medicine? Well, I m here to explain

Food and Drug Administration

USP s mission is to improve global health through public. standards and related programs that help ensure the quality,

SUMMARY REPORT. Antimicrobials Sold or Distributed for Use in Food-Producing Animals

FDA TRANSPARENCY INITIATIVE: IMPROVING TRANSPARENCY TO REGULATED INDUSTRY

Food and Drug Administration COMMISSIONER S. Fellowship Program. Protecting Public Health Through Science and Regulation

Blood, Plasma, and Cellular Blood Components INTRODUCTION

PRINCIPLES OF VETERINARY MEDICAL ETHICS OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (AVMA)

Transcription:

Center for Veterinary Medicine: Overview Sanja Modric, DVM, PhD Office of New Animal Drug Evaluation Center for Veterinary Medicine Food and Drug Administration USP Veterinary Stakeholder Forum, 11-09-2012

FDA Center for Veterinary Medicine What we regulate: Animal drugs Animal feeds Veterinary devices What we do not regulate: The practice of veterinary medicine Vaccines for animals (USDA)

Core CVM Mission Protecting human and animal heath

Core CVM Mission Companion Animals Increase quality of life through medical interventions Ensure the availability of animal drugs that prevent the spread of zoonotic diseases 58 62% of households own a pet 44% of dogs sleep in the owners bed

Core CVM Mission Food Producing Animals Improve animal welfare and health Improve animal production Increase the availability of food supply to meet the needs of a growing human population

FDA CVM: Major Responsibilities Evaluation of data on proposed new veterinary products prior to approval Monitoring for violative marketed products through surveillance programs Ensuring animal feed safety Initiating legal action, if necessary, to bring violators into compliance with the law Conducting research to support Center activities Educating consumers and regulated industry USP Veterinary Stakeholder Forum, 11/09/2012

Laws Enforced by CVM Federal Food, Drug and Cosmetics (FFD&C) Act (1938) Animal Drug Amendments of 1968 Specific Animal Drug Acts: Animal Drug Availability Act of 1996 Animal Medicinal Drug Use Clarification Act of 1994 (AMDUCA) Generic Animal Drug and Patent Term Restoration Act (GADPTRA) Minor Use/Minor Species Act of 2004 (MUMS) Animal Drug User Fee Act of 2008 (ADUFA) Animal Generic Drug User Fee Act of 2008 (AGDUFA)

Federal Food, Drug, and Cosmetic Act (1938) Chapter II FFD&C Act Chapter II, Sec. 321(g)(1) The term "drug" means: (A) articles recognized in the official United States Pharmacopoeia, official Homoeopathic Pharmacopoeia of the United States, or official National Formulary, or any supplement to any of them; (B) articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in man or other animals; (C) articles (other than food) intended to affect the structure or any function of the body of man or other animals; (D) articles intended for use as a component of any article specified in clause (A), (B), or (C)

Federal Food, Drug, and Cosmetic Act (1938) Chapter V Sec. 501 A drug shall be deemed to be adulterated if it purports to be or is represented as a drug the name of which is recognized in an official compendium (USP-NF), and its strength differs from, or its quality or purity falls below, the standards set forth in such compendium. Such determination as to strength, quality, or purity shall be made in accordance with the tests or methods of assay set forth in such compendium Sec. 502 A drug shall be deemed to be misbranded - if it purports to be a drug the name of which is recognized in an official compendium, (USP-NF) unless it is packaged and labeled as prescribed therein

FDA - Approval and Regulations of Animal Drugs Similar in theory and practice to the approval of human drugs Multiple species considerations Approval only for specific uses/species with adequate safety and effectiveness data Companion-animal drugs - more similar to human approval process Food-animal drugs - human food safety requirements: Toxicology (Delaney clause FD&C amendment of 1938) Limits for drug residues set

Code of Federal Regulations (CFR) The codification of the general and permanent rules published in the Federal Register by the executive departments and agencies of the Federal Government Divided into 50 titles that represent broad areas subject to Federal regulation: CFR Title 21 - Food and Drugs: Parts 1 to 1499

Human vs. Animal Drugs: Comparison of CFR* What s the same? CDER Title CVM Title 300 General 500 Animal Drugs, Feeds, Related Products 310 New Drugs 510 New Animal Drugs 312 Investigational New Drug Application 314 Applications for FDA Approval 511 New Animal Drugs for Investigational Use 514 New Animal Drug Applications 316 Orphan Drugs 516 New Animal Drugs for MUMS Tables modified from Dr. Michael Murphy s presentation at the AAVPT Veterinary Drug Regulatory Life- Cycle Course (February 2011)

Human vs. Animal Food: Comparison of CFR What s similar? CFSAN Title CVM Title 101 Food Labeling 501 Animal Food Labeling 102 Common or Usual Name 109 Unavoidable contaminants in food 502 Common or Usual Name for Nonstandardized animal foods 509 Unavoidable contaminants in animal food 170 Food additives 570 Food Additives 171 Food additive petitions 571 Food Additive Petitions

CFR What s Unique for Vet. Drugs CVM Title 515 Medicated feed mill license 520 Oral dosage form new animal drugs 522 Implantation or injectable dosage form new animal drugs 524 Ophthalmic and topical dosage form new animal drugs 526 Intramammary dosage form 528 New animal drugs in genetically engineered animals 529 Certain other dosage form new animal drugs 530 Extralabel drug use in animals 556 Tolerances for residues of new animal drugs in food 558 New animal drugs for use in animal feeds

New Animal Drugs Code of Federal Regulation Title 21 Food and Drugs Chapter I Food and Drug Administration Subchapter E- Animal Drugs, Feeds, and Related Products Part 510 New Animal Drugs: The term new animal drug means any drug intended for use for animals other than man, including any drug intended for use in animal feed but not including such animal feed

Critical Standards for Evaluation of New Animal Drugs Safety Human Food Target Animal Environmental User Safety Effectiveness - Substantial Evidence Quality Manufactured Product Properly Labeled Product

FDA and USP FDA Protects public and animal health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biologial products, medical devices, food, cosmetics, dietary supplements USP Sets standards for the identity, strength, quality, and purity of medicines, food ingredients, and dietary supplements No enforcement role; enforcement through FDA

FDA and USP FDA Protects public and animal health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products, medical devices, food, cosmetics, dietary supplements USP Sets standards for the identity, strength, quality, and purity of medicines, food ingredients, and dietary supplements No enforcement role; enforcement through FDA

FDA (CVM) and USP CVM responsibilities: Review of bi-monthly U.S. Pharmacopeial Forum (USP-PF) issuances and frequent U.S. Pharmacopeia-National Formulary (USP-NF) revision proposals Input from pertinent office(s)/division(s) Collaboration with CDER (Compendial Operations) Feedback to USP on materials posted in PF or in the USP-NF as they relate to veterinary drugs

CVM and USP Collaborations Expert Committees: General Chapters Dosage Forms: Modric General Chapters Chemical Analysis: TBD Nomenclature, Safety and Labeling: Modric Monographs Small molecules 3: Modric Compounding: Bray, Modric

CVM and USP Collaborations Expert Panels: Metal Impurities: Guo Veterinary Drugs Solubility Criteria: Martinez and Modric

Thank you! http://www.fda.gov/animalveterinary/default.htm